Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

1.9%

1 terminated/withdrawn out of 54 trials

Success Rate

93.3%

+6.8% vs industry average

Late-Stage Pipeline

22%

12 trials in Phase 3/4

Results Transparency

0%

0 of 14 completed trials have results

Key Signals

20 recruiting

Enrollment Performance

Analytics

N/A
21(52.5%)
Phase 4
7(17.5%)
Phase 2
6(15.0%)
Phase 3
5(12.5%)
Phase 1
1(2.5%)
40Total
N/A(21)
Phase 4(7)
Phase 2(6)
Phase 3(5)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (54)

Showing 20 of 54 trials
NCT05738642Not ApplicableCompleted

Efficacy and Safety of Early Use PCC in Severe Trauma

Role: collaborator

NCT04866667Completed

Observational Study of ASCVD Risks of Type 2 Diabetes in East China

Role: collaborator

NCT07507825Phase 2Not Yet Recruiting

Exploratory Study of Venetoclax, Homoharringtonine, Azacitidine Plus G-CSF for Newly Diagnosed AML (VHAG)

Role: collaborator

NCT06792786Not ApplicableRecruiting

A Multicenter Prospective Study Evaluating Concurrent Chemoradiotherapy Following Induction Immunochemotherapy for Esophageal Cancer Based on Dynamic ctDNA Monitoring

Role: collaborator

NCT07040358Active Not Recruiting

Rapid Abdominal Diagnosis With AI & Radiology

Role: collaborator

NCT07395596Phase 4Recruiting

Remimazolam for Bronchoscopy in High-Risk Patients

Role: collaborator

NCT07362797Not ApplicableNot Yet Recruiting

Clinical Application of Right Visual Double Lumen Tube in Thoracoscopic Surgery for Adult Patients

Role: collaborator

NCT07360002Not ApplicableNot Yet Recruiting

The Randomized Controlled Study of Shenqi Yishen Granules in the Treatment of IgA Nephropathy

Role: collaborator

NCT07340255Not ApplicableRecruiting

The 90% Effective Ventilation Pressure (EP90) for Esophageal Insufflation Avoidance During Anesthesia Induction

Role: lead

NCT05722405Phase 4Recruiting

Ixazomib Plus Low-dose Lenalidomide Versus Ixazomib Alone for Maintenance Treatment of High Risk Multiple Myeloma

Role: collaborator

NCT06587386Phase 4Completed

The Minimum Effective Dose (ED90) of Liposomal Bupivacaine for Preserving Motor Function

Role: lead

NCT07260266Not ApplicableNot Yet Recruiting

Effect of Transcutaneous Auricular Vagus Nerve Stimulation on Postoperative Opioid Consumption in Patients Undergoing Major Abdominal Surgery

Role: lead

NCT07272954Not ApplicableNot Yet Recruiting

Effects of Ultrasound-Guided Stellate Ganglion Block and Transcutaneous Auricular Vagus Nerve Stimulation on Sleep Quality After Radical Mastectomy for Breast Cancer

Role: lead

NCT07266168Not ApplicableNot Yet Recruiting

Efficacy and Safety of Ivarmacitinib in the Treatment of Patients With Polymyalgia Rheumatica

Role: collaborator

NCT06462313Not ApplicableCompleted

Dobutamine for Management of Surgical Patients With Septic Shock

Role: collaborator

NCT05171842Completed

Dissection of the Superior Mesenteric Artery

Role: collaborator

NCT06520163Phase 3Recruiting

Comparison Study of EAP and Disease-Specific Chemotherapy Regimens in Hematopoietic Stem Cell Mobilization for Lymphoma

Role: collaborator

NCT07088757Phase 4Recruiting

Low-Dose vs Standard-Dose Indomethacin for Preventing Post-ERCP Pancreatitis

Role: collaborator

NCT07203248Not Yet Recruiting

Chinese Real-world Study of Treatment of Vestibular Migraine

Role: collaborator

NCT07195812Phase 4Not Yet Recruiting

Rivaroxaban for Slow Coronary Flow After PCI in STEMI

Role: collaborator